Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionSanders Morris Harris Llc
Latest Disclosed Ownership21,505 shares
Latest Disclosed Value $ 1,417,395
Sanders Morris Harris Llc ownership in 1CYTK / Cytokinetics, Incorporated

On April 9, 2026 - Sanders Morris Harris Llc filed a 13F-HR form disclosing ownership of 21,505 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $1,161,270 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 0 shares of Cytokinetics, Incorporated. The current value of the position is $1,340,192 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 21,505 21,505 1,417 0.2247
2026-01-08 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 0 -100.00 0
2025-10-07 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 21,505 21,505 1,182 0.1559
2025-07-30 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 0 -21,505 -100.00 0 -100.00
2025-04-09 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 21,505 0 0.00 806 -20.28 0.1246
2025-01-15 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 21,505 0 0.00 1,012 -10.93 0.1510
2024-10-09 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 21,505 0 0.00 1,135 -2.58 0.1883
2024-07-12 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 21,505 0 0.00 1,165 -22.69 0.1913
2024-04-11 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 21,505 0 0.00 1,508 -34.25 0.2768
2024-01-10 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 21,505 0 0.00 2,292 280.10 1.1270
2023-10-13 2023-09-30 13F/A-1 CYTOKINETICS COM NEW 23282W605 21,505 0 0.00 603 -15.90 0.1239
2023-07-11 2023-06-30 13F CYTOKINETICS COM NEW 23282W605 21,505 21,505 717 0.1588
2023-04-07 2023-03-31 13F CYTOKINETICS COM NEW 23282W605 0 -21,505 -100.00 0 -100.00
2023-01-13 2022-12-31 13F CYTOKINETICS COM NEW 23282W605 21,505 750 3.61 985 -7.25 0.3731
2022-10-07 2022-09-30 13F CYTOKINETICS COM NEW 23282W605 20,755 -1,000 -4.60 1,062 19.33 0.2601
2022-07-11 2022-06-30 13F CYTOKINETICS COM NEW 23282W605 21,755 0 0.00 890 11.11 0.1947
2022-04-11 2022-03-31 13F CYTOKINETICS COM NEW 23282W605 21,755 0 0.00 801 -19.42 0.1560
2022-02-02 2021-12-31 13F CYTOKINETICS COM NEW 23282W605 21,755 0 0.00 994 18.19 0.1719
2021-10-13 2021-09-30 13F CYTOKINETICS COM NEW 23282W605 21,755 0 0.00 841 97.88 0.1530
2021-07-13 2021-06-30 13F CYTOKINETICS COM NEW 23282W605 21,755 0 0.00 425 -16.34 0.0826
2021-04-19 2021-03-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 21,755 0 0.00 508 20.67 0.1074
2021-04-14 2021-03-31 13F CYTOKINETICS COM NEW 23282W605 20,755 -1,000 484 220,043.0084
2021-01-26 2020-12-31 13F CYTOKINETICS COM NEW 23282W605 21,755 -2,800 -11.40 421 1.94 0.0958
2020-10-16 2020-09-30 13F CYTOKINETICS COM NEW 23282W605 24,555 24,555 413 0.1122
2020-07-09 2020-06-30 13F CYTOKINETICS COM NEW 23282W605 0 -12,155 -100.00 0 -100.00
2020-04-10 2020-03-31 13F/A-1 CYTOKINETICS COM NEW 23282W605 12,155 12,155 145 0.1417
2020-04-09 2020-03-31 13F CYTOKINETICS COM NEW 23282W605 12,155 146
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.